Esperion Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Esperion Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2019 to Q4 2023.
  • Esperion Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $2.1M, unchanged year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.1M $0 0% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $2.1M $0 0% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $2.1M -$507K -19.5% Dec 31, 2021 10-K 2024-02-27
Q4 2020 $2.61M +$2.61M Dec 31, 2020 10-K 2023-02-21
Q4 2019 $0 Dec 31, 2019 10-K 2022-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.